Natural history of urothelial dysplasia of the bladder

American Journal of Surgical Pathology

Volumn 23, Issue 4, 1999, Pages 443-447

  Cheng, Liang ^a,c   Cheville, John C ^b   Neumann, Roxann M ^b   Bostwick, David G ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dysplasia Natural history; Precursor Detection; Prevention; Progression; Urinary bladder

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER DISEASE; CANCER RISK; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; MALE; UROGENITAL TRACT TUMOR; UROTHELIUM;

EID: 0032960964     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199904000-00009     Document Type: Article

References (27)

1. Althausen AF, Prout GR, Daly JJ. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 1976;116:575-80.
2. Baithun SI, Rogers HS, Martin JE, Zuk RJ, Blandy JP. Primary dysplasia of bladder [Letter]. Lancet 1988;I:483.
3. Cooper PH, Waisman J, Johnston WH, Skinner DG. Severe atypia of transitional epithelium and carcinoma of the urinary bladder. Cancer 1973;31:1055-60.
4. Eisenberg RB, Roth RB, Schweinsberg MH. Bladder tumors and associated proliferative mucosal lesions. J Urol 1960;84:544-50.
5. Epstein JI, Amin MB, Reuter VR, Mostofi FK, and the Bladder Consensus Conference Committee. The World Health Organization/International Society of Urologic Pathology consensus classification of urothelial (transitional cell) neoplasms of urinary bladder. Am J Surg Pathol 1998;22:1435-48.
6. Friedell GH, Soloway MS, Hilgar AG, Farrow GM. Summary of workshop on carcinoma in situ of the bladder. J Urol 1986;136: 1047-8.
7. Gibbons RP, Mandler JI, Hartmann WH. The significance of epithelial atypia in noninvasive transitional cell papillary tumors of the bladder. J Urol 1969;102:195-9.
8. Harewood LM. The significance of urothelial dysplasia as diagnosed by cup biopsies. Aust NZ J Surg 1986;56:199-203.
9. Harnden P, Eardley I, Joyce AD, Southgate J. Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol 1996;78:870-5.
10. Hofstadter F, Delgado R, Jakse G, Judmaier W. Urothelial dysplasia and carcinoma in situ of the bladder. Cancer 1986;57:356-61.
11. Kakizoe T, Matumoto K, Nishio Y, Ohtani M, Kishi K. Significance of carcinoma in situ and dysplasia in association with bladder cancer. J Urol 1985;133:395-8.
12. Kiemeney LAMA, Witjes JA, Heijbroek RP, Debruyne FMJ, Verbeek ALM. Dysplasia in normal-looking urothelium increases the risk of tumor progression in primary superficial cancer. Eur J Cancer 1994;30A:1621-25.
13. Landis S, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. Ca Cancer J Clin 1998;48:6-29.
14. Murphy WM, Nagy GK, Rao MK, et al. "Normal" urothelium in patients with bladder cancer. Cancer 1979;44:1050-8.
15. Murphy WM, Soloway MS. Urothelial dysplasia. J Urol 1982;127: 849-54.
16. Nagy GK, Frable WJ, Murphy WM. Classification of premalignant urothelial abnormalities: a Delphi study of the National Bladder Cancer Collaborative Group A. Pathol Ann 982;17:219-33.
17. Murphy WM, Soloway MS. Developing carcinoma (dysplasia) of the urinary bladder. Pathol Ann 1982;17:197-217.
18. Richards B, Parmar MKB, Anderson CK, et al. Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. Br J Urol 1991;67:369-75.
19. Sanchez-Fernandez de Sevilla, Morell-Quadreny L, Gil-Salom M, Perez-Bacete M, Llombart-Bosch A. Morphometric and immunohistochemical characterization of bladder carcinoma in situ and its preneoplastic lesions. Eur Urol 1992;21(Suppl1):5-9.
20. Schade ROK, Swinney J. Precancerous changes in bladder epithelium. Lancet 1968;ii:943-46.
21. Schmitz-Drager BJ, van Roeyen CRC, Grimm MO, et al. p53 accumulation in precursor lesions and early stages of bladder cancer. World J Urol 1994;12:79-83.
22. Shirai T, Fukushima S, Hirose M, Ohshima M, Ito N. Epithelial lesions of the urinary bladder in 313 autopsy cases. Jpn J Cancer Res 1987;78:1073-80.
23. Soini Y, Turpeenniemi-Hujanen T, Kamel D, et al. Br J Cancer 1993;68:1029-35.
24. Wagner U, Sauter G, Mnoch H, et al. Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder. Hum Pathol 1995;26:970-8.
25. Wolf H, Hojgaard K. Urothelial dysplasia concomitant with bladder tumors as a determinant factor for future new occurrences. Lancet 1983;i:134-36.
26. Wolf H, Olsen PR, Hojgaard K. Urothelial dysplasia concomitant with bladder tumors: a determinant for future new occurrence in patients treated by full-course radiotherapy. Lancet 1985;i:1005-8.
27. Zuk RJ, Rogers HS, Matin JE, Baithun SI. Clinicopathological importance of primary dysplasia of bladder. J Clin Pathol 1988; 41:1277-80.